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Abstract
Objective: Bone marrow and umbilical cord stromal cells are multipotential stem cells 
that have the ability to produce growth factors that play an important role in survival and 
generation of axons. The goal of this study was to evaluate the effects of the two different 
mesenchymal stem cells on peripheral nerve regeneration. 
Materials and Methods: In this experimental study, a 10 mm segment of the left sciatic 
nerve of male Wistar rats (250-300 g) was removed with a silicone tube interposed into 
this nerve gap. Bone marrow stromal cells (BMSCs) and human umbilical cord stromal 
cells (HUCSCs) were respectively obtained from rat and human. The cells were sepa-
rately cultured and transplanted into the nerve gap. The sciatic nerve regeneration was 
evaluated by immunohistochemistry, and light and electron microscopy. Moreover, histo-
morphology of the gastrocnemius muscle was observed.    
Results: The nerve regeneration in the BMSCs and HUCSCs groups that had received 
the stem cells was significantly more favorable than the control group. In addition, the BM-
SCs group was significantly more favorable than the HUCSCs group (P<0.05).                    
Conclusion: The results of this study suggest that both homograft BMSCs and het-
erograft HUCSCs may have the potential to regenerate peripheral nerve injury and 
transplantation of BMSCs may be more effective than HUCSCs in rat.         
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Introduction
Peripheral nerve injury is a serious health prob-
lem for the society today affecting 2.8% of trauma 
patients with many of them acquiring life-long 
disability (1). Peripheral nerve injuries are tradi-
tionally treated with a nerve autograft that supplies 
structural support for sprouting axons originating 
from the proximal nerve stump. Major disadvan-
tages of this method include: i. Multiple surger-
ies, ii. Loss of function or sensation at the donor 
site, iii. Need to sacrifice a healthy nerve and iv. 
Deficiency of graft material available for repair. 
Therefore, an effective alternative to the nerve au-
tograft technique is required (2-4). One approach 
that has recently been noted is stem cell therapy 
which is likely to be effective for the treatment 
of neurotraumatic injuries and neurodegenerative 
diseases (5). Because stem cells are significant 
seeding cells for peripheral nerve regeneration, 
special consideration has been given to the devel-
opment of a rich and accessible cellular storage 
of this cell-type (2, 4). Bone marrow stromal cells 
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(BMSCs) and human umbilical cord stromal cells 
(HUCSCs) are two types of MSCs that have the 
ability to differentiate into many cell lines such as 
fat, muscle, and neuron and Schwann cells (6-10). 
One of the greatest benefits of MSCs is that they 
are easily accessible and can be readily expanded 
in large-scale for transplantation (5).
Moreover, BMSCs and HUCSCs are cells able 
to produce growth factors and anti-inflammatory 
cytokines that play important roles in survival 
and generation of axons. Some of these factors 
include nerve growth factor (NGF), brain-derived 
nerve growth factor (BDNF), vascular endothelial 
growth factor (VEGF), ciliary neurotrophic factor 
(CNTF) and glial-cell-line-derived growth factor 
(GDNF) (11, 12). Thus, transplantation of BMSCs 
and HUCSCs may be useful for the regeneration of 
peripheral nerves after injury (11-15).
In this study, we evaluated the effects of trans-
plantation of BMSCs and HUCSCs on peripheral 
nerve regeneration. This was done to determine 
which cell-type is more effective based on the sur-
viving factors of the stem cells.
Materials and Methods
Animal model
In this experimental study, 24 male Wistar rats 
(250-300g) were obtained from Pasteur Institute 
of Iran. All animals had free access to food and 
water. Rats were randomly divided into 3 groups 
(n=8 in each group), namely the BMSC transplan-
tation group, the HUCSC transplantation group 
and the control group. All procedures, including 
the use and care of animals, were approved by the 
Research Council of Iran University of Medical 
Sciences.
Bone marrow stromal cell culture
BMSC culture was prepared according to the 
method previously described by Zarbakhsh et al. 
(16). Briefly, after killing rats, femurs and tibias 
were dissected out. The bone marrow was ejected 
with 10 ml of Dulbecco’s Modified Eagle Medium 
(DMEM, Sigma, Aldrich) and cultured in DMEM 
containing 15% fetal bovine serum (FBS, Sigma 
Aldrich, USA), 2 mM L-glutamine (Sigma Al-
drich, USA), and 100 mg/ml kanamycine (Sigma 
Aldrich, USA), incubated at 37˚C, with 95% hu-
midity and 5% CO2. After 48 hours, nonadherent 
cells were removed by replacing the medium. The 
cells were expanded when they reached about 80% 
confluence and then passaged four times once eve-
ry 7 days.
Human umbilical cord stromal cell culture
Human umbilical cords of both sexes were col-
lected from full-term births after either cesarean sec-
tion or normal vaginal delivery with consent from the 
mothers according to the Institute’s Human Ethical 
Committee guidelines at Milad hospital, Tehran, Iran. 
The umbilical cord was washed in sterile phosphate 
buffered saline (PBS, Gibco, Germany) and blood 
vessels were removed. The remaining tissues were 
then cut into small pieces and were transferred into 
culture flasks with DMEM containing 10% FBS, 100 
U/ml penicillin and 100 μg/ml streptomycin (Sigma 
Aldrich, USA), incubated at 37˚C with 95% humid-
ity and 5% CO2. The non-adherent cells were washed 
with PBS after 48 hours and adherent cells were de-
fined. HUCSCs were expanded when they reached 
about 80% confluence and then passaged three times 
once every 5 days (12, 17, 18).
Differentiation potential of the stem cells
To confirm the differentiation capacity of the stem 
cells, BMSCs and HUCSCs at passage 2 were indi-
vidually treated with adipogenic induction medium 
for 21 days. Adipogenic induction medium comprised 
10% FBS, 10 nM dexamethasone, 5 g/ml insulin, 0.5 
M 3-isobutyl-1-methylxantine and 200 g/ml indo-
methacin in DMEM (Sigma Aldrich, USA). The cells 
were then fixed with buffered formalin (10%) in PBS 
for 10 minutes at room temperature and stained with 
oil-red O for 1 hour. Adipogenesis was observed after 
the differentiation process was completed (11, 18, 19).
Analysis of cell surface antigen markers
To analyze the expression of surface markers of the 
stem cells, flow cytometry was performed. At least 
200,000 cells were incubated with fluorescence-
labeled monoclonal antibodies against CD29-PE, 
CD34-FITC, CD44-PE and CD45-FITC (Sigma Al-
drich, USA) Following a 10 minutes wash in PBS, 
the labeled cells were analyzed using a FACS Calibur 
flow cytometry apparatus (2, 20).
Transplantation procedure
The transplantation procedure of the cells was 
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performed according to that previously described 
by Zarbakhsh et al. (16). Briefly, rats were anes-
thetized and the left sciatic nerve was exposed 
at the mid-thigh. A 10 mm segment of the nerve 
was then removed and a 12 mm silicone tube was 
interposed into this nerve gap. Silicone tube was 
selected because it is the most reliable prosthetic 
in modeling the bridge conduit. Also, the inner 
diameter of silicone tube is similar to the rat sci-
atic nerve (21). Both ends of the nerve were fixed 
into the tube with a 10-0 nylon suture. The silicone 
tube in both experimental groups (BMSCs and 
HUSCs) was filled with fibrin gel seeded with 
about 500,000 cells. For the control group, it was 
filled with fibrin gel without any cells. Finally the 
skin was sutured with 5-0 silk.
Immunohistochemistry of the cells
BMSCs and HUCSCs were separately labeled 
with anti-BrdU (Bromodeoxyuridin, Sigma Al-
drich, USA) and rhodamine (Sigma Aldrich, USA) 
as the primary and secondary antibodies respec-
tively in the sciatic nerve to show the presence and 
also the viability of the transplanted cells after four 
weeks. The labeling protocol has been previously 
described (16, 22-24).
Light microscopy
For light microscopy examination of the nerves, 
12 weeks after transplantation, the rats were sac-
rificed and the regenerated nerves within the sili-
cone tubes were harvested. The nerve grafts were 
fixed immediately in 2.5% glutaraldehyde solu-
tion. Then, the nerve tissues were post-fixed in 2% 
osmium tetroxide, dehydrated, embedded in Epon 
resin, semithin cross sectioned (700 nm) from the 
central portion using an ultra microtome and stained 
with toluidine blue. The nerve sections were observed 
under an Olympus light microscope (PROVIS Ax70, 
Japan). The number of axons and blood vessels, and 
the diameter of the axons were calculated in random-
ly selected fields (2, 11, 21, 25, 26).
Electron microscopy
With preparation of specimens for toluidine blue 
staining, the thickness of the myelin sheath was 
also evaluated using transmission electron mi-
croscopy (TEM). Ultrathin sections (70 nm) were 
placed on 300-mesh copper grids, stained with 5% 
uranyl acetate in 70% ethanol (Razi, Iran) for 5 
minutes, dried, counterstained with lead citrate for 
5 minutes, dried and examined on a Zeiss EM 10 
CR TEM (Jenna, Germany) (2, 11, 21, 27).
Histomorphology of the muscle
Along with the removal of the left sciatic nerve, 
the left gastrocnemius muscle was also removed. 
Cross sections of the muscle were fixed in phos-
phate buffered saline containing 4% formalde-
hyde, and routine paraffin-embedded sections 
were produced. The 5 µm paraffin-embedded sec-
tions were rehydrated using xylene and a graded 
alcohol series, and stained with hematoxylin and 
eosin (H&E) to observe the cellular morphology, 
and fibrosis and degenerative changes under a 
light microscopy (Olympus, Japan) (21).
Statistical analysis
All data were analyzed by one-way ANOVA 
followed by the Tukey test. Obtained data were 
presented as mean ± SD. The significance level of 
P<0.05 was considered statistically significant.
Results
Culture, differentiation and characterization of 
bone marrow stromal cells and human umbilical 
cord stromal cells
BMSCs are typically isolated from other cells 
by sticking to plastic. Nonadherent cells were re-
moved by changing the medium at 72 hours and 
every 3 days thereafter. By day 7 in culture, the 
attached cells had developed into an adherent layer 
containing abundant dispersed spindle-like cells. 
By day 14 in culture, the primary BMSCs had pro-
liferated and started to form a nearly continuous 
layer comprised mainly of fibroblast-like cells. 
By repeating passages, the fibroblast-like cells be-
came morphologically homogeneous (Fig.1A).
The isolated HUCSCs began to attach to the 
floor of flask after 6 hours. At 24 hours, the at-
tached cells exhibited ovoid and spindle-shaped 
fibroblast-like morphology. The HUCSCs pro-
liferated markedly faster than the BMSCs and in 
the third passage became relatively homogeneous 
with elongated spindle-like morphology (Fig.1B).
To determine the differentiation potential of the 
stem cells, BMSCs and HUCSCs were treated 
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with adipogenic induction medium and adipogen-
esis was seen with oil-red O staining (Fig.1C, D).
Flow cytometry analysis demonstrated that these 
stem cells were immunopositive for markers 
of mesenchymal stromal stem cells, CD29 and 
CD44, and were immunonegative for hematopoi-
etic markers, CD34 and CD45 (Fig.2).
Zarbakhsh et al.
Fig.1: Cultured A. Bone marrow stromal cells (BMSCs), B. Human umbilical cord stromal cells (HUCSCs) at passage 3, C. Differentiation po-
tential of bone marrow stromal cells and D. Human umbilical cord stromal cells [into adipocytes as red drops (Oil-red O staining)] (×200). 
Arrows show the nucleus of the cells.
Fig.2: Flow cytometry results showing bone marrow stromal cells (BMSCs) and human umbilical cord stromal cells (HUCSCs) being positive 
for A, C. CD29 and CD44 and B, D. Negative for CD34 and CD45.
A B
C D
A B
C D
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Immunohistochemical analysis of cells
The BMSCs and the HUCSCs were successfully 
labeled as red spots were visible in the cross sec-
tions of the sciatic nerves. These results confirmed 
the presence and also the viability of the trans-
planted cells into the silicon tube between the two 
ends of the nerve (4 weeks after transplantation) 
(Fig.3).
Histological comparisons of the nerve
Twelve weeks after transplantation, the surface of 
the tube was replaced with vascularized connective 
tissue. In all groups, axons traversed the whole length 
of the silicone tube. In the silicone tube, there was 
a matrix consisting of capillaries, regenerated axons 
and connective tissue. There was almost no inflam-
matory reaction within the tube (Fig.4).
BMSC and HUCSC Transplantation in Peripheral Nerve Regeneration
Fig.3: Immunohistochemistry of A. Bone marrow stromal cells (BMSCs), B. Human umbilical cord stromal cells (HUCSCs), C. Labeled with 
anti-BrdU antibody and negative control [without the primary antibody of BMSCs and D. HUCSCs] in cross sections of the sciatic nerves 4 
weeks after transplantation (×100). Arrows show the labeled cells. 
Fig.4: A. The silicone tube between the ends of the nerve after surgery. Arrows show the two ends of the nerve in the silicone tube and 
B. Arrow shows regenerated nerve in the silicone tube 12 weeks after transplantation. The black star shows the opened silicone tube and 
the white star shows connective tissue around the nerve and the silicone tube.
A B
A
C
B
D
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Histological evaluation of the sciatic nerve regener-
ation was undertaken using light and electron micros-
copy. The results of light microscopy consisted of the 
number of axons and blood vessels, and the diameter 
of axons (Fig.5A-C). The results of electron micros-
copy consisted of the thickness of the myelin sheath 
(Fig.5D-F). In the experimental groups, a typical pat-
tern of nerve regeneration was observed consisting 
of a newly formed perineurium that included nerve 
fascicles of myelinated and unmyelinated axons with 
further neovascularization. However, smaller axons 
with thinner myelin sheath and less neovasculariza-
tion were seen in the control group. All histological 
data showed that the regeneration in the experimen-
tal groups (BMSCs and HUCSCs) was significantly 
greater than the control group. Similarly, the regenera-
tion in the BMSC group was significantly greater than 
the HUCSC group (P<0.05, Fig.6).
Fig.5: A-C. Semithin cross-sections stained with Toluidine Blue (×400) and D-F. Transmission electron photomicrographs of cross sections 
of the regenerated sciatic nerves 12 weeks after transplantation. A, D. The control group showed a relatively low number of axons and 
small myelinated axons with thin myelin sheaths (magnification D: ×1500), B, E. The bone marrow stromal cell group showed regenera-
tion with myelinated axons and proper myelin sheaths (magnification E: ×2000) and C, F. The human umbilical cord stromal cell group 
showed a fairly good number of axons and many myelinated and non-myelinated axons with preserved myelin sheaths (magnification F: 
×2000). Arrows show the blood vessels.
A
C
E
B
D
F
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Histomorphological observation of the muscle 
Twelve weeks after transplantation, histomorpho-
logical observation of the gastrocnemius muscle 
showed there were closely packed muscle fibers in 
the experimental groups (BMSCs and HUCSCs) 
while generalized muscle atrophy with increased 
fibrosis was observed in the control group (Fig.7).
BMSC and HUCSC Transplantation in Peripheral Nerve Regeneration
Fig.6: Histological differences of the sciatic nerve between the control and the experimental groups [bone marrow stromal cells (BMSCs) 
and human umbilical cord stromal cells (HUCSCs)] 12 weeks after transplantation. A. The number of axons, B. The number of blood ves-
sels, C. The diameter of axons and D. The thickness of myelin sheath. *; P<0.05 vs. control group.
Fig.7: Cross sections of the gastrocnemius muscles (12 weeks after transplantation) stained with Hematoxylin and Eosin (H&E) (×200). A. 
The control group showed severe muscle atrophy with increased fibrosis, B. The bone marrow stromal cell (BMSCs) group showed aligned 
muscle bundles with low fibrosis and C. The human umbilical cord stromal cell (HUCSCs) group displayed mild fibrosis. 
A B
C D
A B C
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Discussion
Nerve autograft is common used for peripheral 
nerve defects but the length of available nerve 
grafts is limited. Nerve regeneration using non-
biological materials such as silicone tubes has 
been attempted for large nerve defects that cannot 
be treated by nerve autografting (4, 26). Recent 
experimental studies demonstrate the beneficial 
effects of transplanted MSCs in regeneration of 
damaged peripheral nerve tissues (6, 9, 11, 28). 
We therefore aimed to evaluate the effects of trans-
plantation of BMSCs and HUCSCs on histological 
regeneration of peripheral nerve. 
BMSCs and HUCSCs as two types of MSCs that, 
according to several reports, can repair peripheral 
nerve injuries (6, 9, 11, 28). Comparison of dif-
ferent cell types may result in the identification of 
cells with a greater ability to regenerate peripheral 
nerves. This may lead to a novel clinical approach 
for applying these cells to replace the highly in-
vasive peripheral nerve autograft technique (2-4).
We show that BMSC and HUCSC cells could 
survive in the silicone tube within the gap between 
the two ends of the nerve after 4 weeks of trans-
plantation. These findings were consistent with 
various reports (2, 16, 24, 29, 30). We also show 
that these stem cells have the ability to differenti-
ate into another cell type (adipocyte) which agrees 
with other reports(9, 18-20, 28, 31, 32).
Moreover, based on surface marker expressions, 
BMSCs and HUCSCs had the characteristics of 
multipotent MSCs, also consistent with other re-
ports (2, 17, 20).
MSCs are emerging as strong candidates par-
ticularly for cellular therapies for at least three rea-
sons. First, they can be isolated from a wide range 
of autologous sources with some readily accessi-
ble. Secondly, their high proliferative potential al-
lows for rapid expansion ex vivo, while maintain-
ing multipotentiality. Finally, these cells produce 
nerve growth factors such as NGF, BDNF, GDNF, 
CNTF, VEGF and NT-3 as well as substantial ex-
tracellular matrix proteins such as collagen I, col-
lagen IV, fibronectin and laminin (11-15, 33-35).
These results were consistent with several re-
ports (6, 9, 36-38). The greater regeneration of 
the number, diameter and myelin thickness of the 
axons in the experimental groups as compared 
with the control group could probably be due to 
the role of the stem cells in producing growth fac-
tors stated above and enabling cells to differentiate 
into Schwann cells that directly support the growth 
of axons (11-15, 33-35, 38). Fan et al. (13) have 
shown that VEGF can cause neovascularization. 
Therefore, the greater number of blood vessels 
in the experimental groups as compared with the 
control group may be due to the role of VEGF that 
was produced by the stem cells. The greater regen-
eration in the BMSC group than the HUCSC group 
is probably due to homografts being often more 
favorable than heterografts (39). In recent studies, 
heterograft from human into experimental animals 
has been performed extensively. Zhilai et al. (12) 
transplanted HUCSCs into rat with spinal cord in-
jury. Zhang et al. (17) transplanted HUCSCs into 
ataxic mice. Moradi et al. (40) cultured Schwann 
cells from aborted human fetuses and transplanted 
the cells into rats with spinal cord injury. Lee et 
al. (30) transplanted HUCSCs into dogs with spi-
nal injury. Gartner et al. (41) evaluated the effects 
of HUCSCs on rat sciatic nerve regeneration af-
ter neurotmesis injuries. Due to the difficulties in 
providing homograft cells for humans, heterograft 
cells may provide a bright future for cell therapy.
The risk of rejection in our study was minimal 
since the MSCs secrete immunomoulatory factors 
and anti-inflammatory cytokines, thus modulating 
immune and inflammatory responses (12, 41-44).
Since both cell types (BMSCs and HUCSCs) 
have the ability to release neurotrophic factors and 
extracellular matrix proteins, comparative analysis 
may lead to a more efficient treatment approach 
based on the measure of peripheral nerve regen-
eration.
Conclusion
The results of this study suggest that both homo-
graft BMSCs and heterograft HUCSCs may have 
the potential to regenerate peripheral nerve injury 
with BMSC transplantation being more effective 
than HUCSC in rat.
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